Glucosodiene: Opening a New Branch of Chemotherapic Sciences Called Toxinutromedicanical-Chemotherapy

Abstract

Chemotherapy is a widely employed treatment modality
in the fight against cancer aiming to eliminate both normal
and cancerous cells. However, its non-discriminatory nature
leads to severe side effects [1].
On the other hand, the treatment involving glucosodiene
has shown promising results, particularly after the
submission of a manuscript presenting its effectiveness in
treating the first human case of triple-negative breast cancer
(TNBC) that had metastasized to the bones [2].
The patient achieved complete recovery in less than a
month. Research studies proposing and discussing the impact
of glucosodiene as a promising theory for cancer treatment
have shed light on its ability to modify glucose and endow it
with alkaline properties [3,4]. This modification potentially
allows for the destruction or metabolic inhibition of glucose
within the tumor, a phenomenon known as the Warburg
effect. Despite the ongoing extensive study to document the
final chemical structure of glucosodiene [5-8], this approach
and its results may herald a new branch of chemotherapy
known as “toxinutromedicanical-chemotherapy.”